Association Study between Schizophrenia and Monocyte Chemoattractant Protein-1(MCP-1) Gene Polymorphism / 신경정신의학

ABSTRACT

OBJECTIVES: This study was aimed at comparing the Monocyte Chemoattractant Protein-1 (MCP-1) gene polymorphic variants of schizophrenics with those of normal controls, and to investigate its contribution to the development of schizophrenia. METHODS: One hundred and thirty five schizophrenics in accordance with DSM-IV criteria and one hundred and fourteen healthy individuals participated in this study. DNA was extracted from peripheral blood using proteinase K, and the MCP-1 gene promoter region was amplified by polymerase chain reaction (PCR). Gene typing was analyzed by restriction fragment length polymorphism (RFLP) using restriction enzyme PvuII. RESULTS: Distribution of the genotypes and alleles of MCP-1 gene in the patient group was not significantly different from that of the control group (p=0.145 and p=0.122, respectively). There was difference in the frequencies of genotypes between positive and negative subgroup (p=0.035), but no difference in frequencies of alleles between the two subgroups (p=0.078). There was no difference in scores of PANSS general, positive and negative subscale, the age of onset, the presence or absence of family history between patients with or without -2518G allele (p=0.979, p=0.378, p=0.056, p=0.256 and p=0.301, respectively). CONCLUSION: We suggest that the polymorphism in the MCP-1 promotor gene may be the possible marker for subgouping of negative type schizophrenia.